- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PF-04449913
Total 1299 results
-
PfizerCompleted
-
PfizerActive, not recruitingRenal Cell Carcinoma | Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Squamous Cell Carcinoma of the Head and Neck | Bile Duct Cancer | Endometrial Cancer | Urothelial Cancer | Lung Squamous Cell Carcinoma | Melanoma CancerUnited States, Taiwan, Korea, Republic of, Australia, Slovakia
-
InvicroCompletedHealthy Male VolunteersUnited States
-
PfizerCompletedHealthy ParticipantsNetherlands
-
PfizerCompletedPlaque Psoriasis | Atopic DermatitisUnited States, Canada, United Kingdom, Japan
-
PfizerTerminatedProstatic NeoplasmsUnited States
-
PfizerCompletedHealthy ParticipantsUnited States
-
PfizerCompleted
-
PfizerCompletedAlzheimer's DiseaseKorea, Republic of, Canada, United States, Australia, United Kingdom, Belgium
-
PfizerCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Canada
-
PfizerCompletedAnorexia | Breast Cancer | Fatigue | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Cachexia | Non-small Cell Lung Cancer | Loss of AppetiteUnited States, Canada
-
PfizerWithdrawnInflammatory Bowel DiseaseUnited States
-
PfizerCompleted
-
PfizerCompleted
-
PfizerWithdrawn
-
PfizerTerminated
-
PfizerCompletedAcute Myeloid LeukemiaJapan
-
PfizerCompletedAcute Myeloid LeukemiaUnited States, Spain, Germany, Italy, Poland, Canada
-
PfizerCompletedHealthy VolunteersUnited States
-
PfizerCompletedLeukemia, Myeloid, AcuteUnited States, Spain, Canada, Israel, Korea, Republic of, Taiwan, France, Australia, Germany, Mexico, Japan, Sweden, China, Austria, Belgium, Czechia, Hungary, Italy, Poland, Romania, Russian Federation, United Kingdom
-
PfizerTerminatedMultiple SclerosisUnited States
-
PfizerCompletedAlopecia AreataChina, United States, Spain, Korea, Republic of, Taiwan, Canada, Australia, Germany, Czechia, Poland, Hungary, Japan, United Kingdom, Argentina, Chile, Colombia, Mexico, Russian Federation
-
PfizerActive, not recruitingHealthy ParticipantsUnited States
-
PfizerCompletedHealthy VolunteerNetherlands
-
PfizerCompletedHealthy ParticipantsUnited States
-
PfizerCompleted
-
PfizerCompletedLiver Fibrosis | Non-Alcoholic Fatty Liver DiseaseUnited States
-
PfizerCompletedType 2 Diabetes MellitusJapan
-
PfizerWithdrawnUlcerative ColitisUnited States
-
PfizerCompletedOcular Hypertension | Primary Open-Angle GlaucomaUnited States
-
PfizerCompletedAlzheimer's DiseaseUnited States
-
PfizerCompletedNon-Alcoholic Fatty Liver Disease (NAFLD)United States
-
PfizerCompleted
-
PfizerCompletedRespiratory Tract Diseases | Lung Diseases | Pulmonary Disease, Chronic Obstructive | COPD | Chronic Obstructive Airway DiseaseGermany
-
PfizerCompletedHepatitis C VirusUnited States
-
PfizerRecruitingGlioma | Melanoma | Colorectal Cancer | Brain Neoplasms | Non-Small Cell Lung Cancer | Thyroid Cancer | Malignant NeoplasmsCanada, United States
-
Quark PharmaceuticalsPfizerTerminatedDiabetes Complications | Diabetic RetinopathyUnited States, United Kingdom, Italy, Israel, Germany, Peru, Denmark, India
-
PfizerCompleted
-
PfizerCompletedDiabetes Mellitus, Type 2United States, Colombia, Spain, Germany, Sweden, Italy
-
PfizerCompletedInfluenza, HumanUnited States
-
PfizerCompleted
-
PfizerCompletedDiabetes Melliuts, Type 2United States
-
PfizerRecruitingPrimary Immune ThrombocytopeniaUnited States, Australia, Canada, Czechia, Poland, Hungary, United Kingdom
-
PfizerTerminatedFocal Segmental Glomerulosclerosis (FSGS)United States, Spain, Czechia, Canada, France, Germany, United Kingdom, Poland, Japan, Mexico, Italy, Slovakia
-
PfizerCompleted
-
PfizerTerminatedIntracerebral HemorrhageSpain, United States, Canada, United Kingdom
-
PfizerCompleted
-
PfizerCompleted